MS 3
MS 3
MS 3
• Cancer encompasses a broad range of diseases of multiple causes that can arise in any cell
of the body capable of evading regulatory controls over proliferation and differentiation.
• Two major dysfunctions present in the process of cancer are (1) defective cellular
proliferation (growth) and (2) defective cellular differentiation.
• Cancer cells usually proliferate at the same rate of the normal cells of the tissue from which
they arise. However, cancer cells divide indiscriminately and haphazardly and sometimes
produce more than two cells at the time of mitosis.
• Protooncogenes are normal cellular genes that are important regulators of normal cellular
processes. When these genes become mutated, they can begin to function as oncogenes
(tumor-inducing genes).
• Since cancer cells arise from normal human cells, the immune response mounted against
cancer cells may be inadequate to effectively eradicate them.
• The process by which cancer cells evade the immune system is termed immunologic escape.
• Tumors can be classified according to anatomic site, histologic (grading), and extent of
disease (staging).
o In the anatomic classification of tumors, the tumor is identified by the tissue of
origin, the anatomic site, and the behavior of the tumor (i.e., benign or malignant).
o In histologic grading of tumors, the appearance of cells and the degree of
differentiation are evaluated pathologically. For many tumor types, four grades are
used to evaluate abnormal cells based on the degree to which the cells resemble the
tissue of origin.
o The staging classification system is based on a description of the extent of the
disease rather than on cell appearance.
• Modalities for cancer treatment with all three goals include surgery, chemotherapy, radiation
therapy, and biologic and targeted therapy.
• The goal of chemotherapy is to eliminate or reduce the number of malignant cells present
in the primary tumor and metastatic tumor site(s).
• Regional treatment with chemotherapy involves the delivery of the drug directly to the
tumor site.
• Chemotherapy-induced side effects are the result of the destruction of normal cells,
especially those that are rapidly proliferating such as those in the bone marrow, lining of the
gastrointestinal system, and the integumentary system (skin, hair, and nails).
• Radiation is the emission and distribution of energy through space or a material medium.
• Radiation is used to treat a carefully defined area of the body to achieve local control of
disease.
• Simulation is a part of radiation treatment planning used to determine the optimal treatment
method by focusing on the geometric aspects of treatment.
• Nurses play a key role in assisting patients to cope with the psychoemotional issues
associated with receiving cancer treatment.
• Educating patients about their treatment regimen, supportive care options (e.g., antiemetics,
antidiarrheals), and what to expect during the course of treatment is important to help
decrease fear and anxiety, encourage adherence, and guide at-home self-management.
• Fatigue is a nearly universal symptom affecting 70% to 100% of patients with cancer.
• The intestinal mucosa is one of the most sensitive tissues to radiation and chemotherapy.
• Nausea and vomiting are common sequelae of chemotherapy and, in some instances,
radiation therapy.
• Biologic and targeted therapy can be effective alone or in combination with surgery,
radiation therapy, and chemotherapy.
• Biologic therapy consists of agents that modify the relationship between the host and the
tumor by altering the biologic response of the host to the tumor cells.
• Targeted therapy interferes with cancer growth by targeting specific cellular receptors and
pathways that are important in tumor growth.
• Capillary leak syndrome, pulmonary edema, bone marrow depression, and fatigue are
associated with biologic therapy.
• Gene therapy is an experimental therapy that involves introducing genetic material into a
person’s cell to fight a disease, such as cancer.
• Cancer patients may develop complications related to the continual growth of the
malignancy into normal tissue or to the side effects of treatment.
• Moderate to severe pain occurs in approximately 50% of patients who are receiving active
treatment for their cancer and in 80% to 90% of patients with advanced cancer.